el4 cells Search Results


90
Korean Cell Line Bank el4 mouse lymphoma
El4 Mouse Lymphoma, supplied by Korean Cell Line Bank, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/el4+cells/el4+lymphoma+cells/pm25114106-67-3-16
Average 90 stars, based on 1 article reviews
el4 mouse lymphoma - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Johns Hopkins HealthCare el4 cells expressing luciferase
El4 Cells Expressing Luciferase, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/el4+cells/el4+cells+expressing+luciferase/10__1172_slash_jci77746-351-6-16
Average 90 stars, based on 1 article reviews
el4 cells expressing luciferase - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Dainippon Sumitomo el4-a2402/kb cells
El4 A2402/Kb Cells, supplied by Dainippon Sumitomo, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/el4+cells/el4+cells/us07939627-277-22-7
Average 90 stars, based on 1 article reviews
el4-a2402/kb cells - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Charles River Laboratories el4 cells
El4 Cells, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/el4+cells/el+4+cells/pmc10442412-303-28-18
Average 90 stars, based on 1 article reviews
el4 cells - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Amplimmune inc murine lymphoma cell line el4.murinebyh1 (el4)
Murine Lymphoma Cell Line El4.Murinebyh1 (El4), supplied by Amplimmune inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/el4+cells/murine+lymphoma+cell+line+el4+murinebyh1++el4+/pmc05632734-72-5-10
Average 90 stars, based on 1 article reviews
murine lymphoma cell line el4.murinebyh1 (el4) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Caliper Life Sciences luciferase expressing el4 cells
Luciferase Expressing El4 Cells, supplied by Caliper Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/el4+cells/luciferase+expressing+el4+cells/pmc03637014-64-11-17
Average 90 stars, based on 1 article reviews
luciferase expressing el4 cells - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Jackson Laboratory el4 cells
El4 Cells, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/el4+cells/el4+cells/pmc05715147-442-10-0
Average 90 stars, based on 1 article reviews
el4 cells - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
European Collection of Authenticated Cell Cultures el4 cells
Effect of necrosome protein expression in TCL cell lines on tolinapant-induced cell death. A, Western blots of parental BW5147, RIPK3 − / − BW5147 and MLKL − / − BW5147 cell lysates (untreated). B, Cytotox-NIR signal captured by real-time microscopy (IncuCyte), detecting membrane permeabilization during lytic cell death after treatment of parental BW5147, RIPK3 − / − BW5147 and MLKL − / − BW5147 cells with tolinapant in the absence or presence of zVAD. C, Western blots of Karpas-299 cells transduced with control gRNA (KARPAS-299-CTR gRNA) or with RIPK3 gRNA (KARPAS-299-RIPK3 gRNA) constructs treated with tolinapant ± zVAD for 0, 2, or 6 hours. D, Real-time microscopy (IncuCyte) measurement of membrane permeabilization by measuring Cytotox-NIR signal after treatment of KARPAS-299-CTR gRNA or KARPAS-299-RIPK3 gRNA cells with tolinapant. E, Western blots of <t>EL4-PAR</t> and CASP8 KO EL4 (EL4-C8KO) cell lysates after 24-hour treatment with tolinapant. F, Real-time microscopy (IncuCyte) measurement of membrane permeabilization by measuring Cytotox-NIR signal after treatment of EL4-PAR or EL4-C8KO cells with tolinapant.
El4 Cells, supplied by European Collection of Authenticated Cell Cultures, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/el4+cells/el4+cells/pmc11155518-38-0-16
Average 90 stars, based on 1 article reviews
el4 cells - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Amersham Life Sciences Inc el4 cells
Effect of necrosome protein expression in TCL cell lines on tolinapant-induced cell death. A, Western blots of parental BW5147, RIPK3 − / − BW5147 and MLKL − / − BW5147 cell lysates (untreated). B, Cytotox-NIR signal captured by real-time microscopy (IncuCyte), detecting membrane permeabilization during lytic cell death after treatment of parental BW5147, RIPK3 − / − BW5147 and MLKL − / − BW5147 cells with tolinapant in the absence or presence of zVAD. C, Western blots of Karpas-299 cells transduced with control gRNA (KARPAS-299-CTR gRNA) or with RIPK3 gRNA (KARPAS-299-RIPK3 gRNA) constructs treated with tolinapant ± zVAD for 0, 2, or 6 hours. D, Real-time microscopy (IncuCyte) measurement of membrane permeabilization by measuring Cytotox-NIR signal after treatment of KARPAS-299-CTR gRNA or KARPAS-299-RIPK3 gRNA cells with tolinapant. E, Western blots of <t>EL4-PAR</t> and CASP8 KO EL4 (EL4-C8KO) cell lysates after 24-hour treatment with tolinapant. F, Real-time microscopy (IncuCyte) measurement of membrane permeabilization by measuring Cytotox-NIR signal after treatment of EL4-PAR or EL4-C8KO cells with tolinapant.
El4 Cells, supplied by Amersham Life Sciences Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/el4+cells/el4+cells/pm10820232-53-4-13
Average 90 stars, based on 1 article reviews
el4 cells - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
BioResource International Inc mouse lymphoma el4 cells rcb1641
Eomes promoted the expression of IFN-γ mRNA in <t>EL4</t> cells. ( A , B ) Whole cell lysates were prepared from Control #1, Control #2, Eomes #1, and Eomes #2 EL4 transfectants and used for Western blotting using anti-FLAG, anti-RelA, and anti-NFATc2 antibodies. Blots were representative of five independent experiments ( A ). The amount of FLAG-Eomes, RelA, and NFATc2 was normalized to that of γ1-actin. The amount of the FLAG-Eomes protein in the Eomes #2 EL4 transfectant was set to 1-fold. The amounts of the RelA protein and NFATc2 protein in the Control #1 EL4 transfectant were set to 1-fold. The FLAG-Eomes protein (fold), RelA protein (fold), and NFATc2 protein (fold) are shown as the mean ± S.E. of five independent experiments. ( C , D ) Control #1, Control #2, Eomes #1, and Eomes #2 EL4 transfectants were treated with (+) or without (−) PMA (10 nM) and IM (1 µM) for 6 h. IFN-γ mRNA ( C ) and IL-2 mRNA ( D ) were measured by quantitative PCR. mRNA levels without PMA and IM in each EL4 transfectant were set to 1-fold. Data are shown as the mean ± S.E. of three independent experiments. * p < 0.05, ** p < 0.01, and *** p < 0.001.
Mouse Lymphoma El4 Cells Rcb1641, supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/el4+cells/mouse+lymphoma+el4+cells+rcb1641/pmc08658103-142-0-10
Average 90 stars, based on 1 article reviews
mouse lymphoma el4 cells rcb1641 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
MultiCell Technologies el-4 cells
Eomes promoted the expression of IFN-γ mRNA in <t>EL4</t> cells. ( A , B ) Whole cell lysates were prepared from Control #1, Control #2, Eomes #1, and Eomes #2 EL4 transfectants and used for Western blotting using anti-FLAG, anti-RelA, and anti-NFATc2 antibodies. Blots were representative of five independent experiments ( A ). The amount of FLAG-Eomes, RelA, and NFATc2 was normalized to that of γ1-actin. The amount of the FLAG-Eomes protein in the Eomes #2 EL4 transfectant was set to 1-fold. The amounts of the RelA protein and NFATc2 protein in the Control #1 EL4 transfectant were set to 1-fold. The FLAG-Eomes protein (fold), RelA protein (fold), and NFATc2 protein (fold) are shown as the mean ± S.E. of five independent experiments. ( C , D ) Control #1, Control #2, Eomes #1, and Eomes #2 EL4 transfectants were treated with (+) or without (−) PMA (10 nM) and IM (1 µM) for 6 h. IFN-γ mRNA ( C ) and IL-2 mRNA ( D ) were measured by quantitative PCR. mRNA levels without PMA and IM in each EL4 transfectant were set to 1-fold. Data are shown as the mean ± S.E. of three independent experiments. * p < 0.05, ** p < 0.01, and *** p < 0.001.
El 4 Cells, supplied by MultiCell Technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/el4+cells/el+4+cells/pmc10948808-259-3-11
Average 90 stars, based on 1 article reviews
el-4 cells - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Virogenetics Corporation el4 cells
Eomes promoted the expression of IFN-γ mRNA in <t>EL4</t> cells. ( A , B ) Whole cell lysates were prepared from Control #1, Control #2, Eomes #1, and Eomes #2 EL4 transfectants and used for Western blotting using anti-FLAG, anti-RelA, and anti-NFATc2 antibodies. Blots were representative of five independent experiments ( A ). The amount of FLAG-Eomes, RelA, and NFATc2 was normalized to that of γ1-actin. The amount of the FLAG-Eomes protein in the Eomes #2 EL4 transfectant was set to 1-fold. The amounts of the RelA protein and NFATc2 protein in the Control #1 EL4 transfectant were set to 1-fold. The FLAG-Eomes protein (fold), RelA protein (fold), and NFATc2 protein (fold) are shown as the mean ± S.E. of five independent experiments. ( C , D ) Control #1, Control #2, Eomes #1, and Eomes #2 EL4 transfectants were treated with (+) or without (−) PMA (10 nM) and IM (1 µM) for 6 h. IFN-γ mRNA ( C ) and IL-2 mRNA ( D ) were measured by quantitative PCR. mRNA levels without PMA and IM in each EL4 transfectant were set to 1-fold. Data are shown as the mean ± S.E. of three independent experiments. * p < 0.05, ** p < 0.01, and *** p < 0.001.
El4 Cells, supplied by Virogenetics Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/el4+cells/el4+cells/pmc00098005-108-58-92
Average 90 stars, based on 1 article reviews
el4 cells - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Effect of necrosome protein expression in TCL cell lines on tolinapant-induced cell death. A, Western blots of parental BW5147, RIPK3 − / − BW5147 and MLKL − / − BW5147 cell lysates (untreated). B, Cytotox-NIR signal captured by real-time microscopy (IncuCyte), detecting membrane permeabilization during lytic cell death after treatment of parental BW5147, RIPK3 − / − BW5147 and MLKL − / − BW5147 cells with tolinapant in the absence or presence of zVAD. C, Western blots of Karpas-299 cells transduced with control gRNA (KARPAS-299-CTR gRNA) or with RIPK3 gRNA (KARPAS-299-RIPK3 gRNA) constructs treated with tolinapant ± zVAD for 0, 2, or 6 hours. D, Real-time microscopy (IncuCyte) measurement of membrane permeabilization by measuring Cytotox-NIR signal after treatment of KARPAS-299-CTR gRNA or KARPAS-299-RIPK3 gRNA cells with tolinapant. E, Western blots of EL4-PAR and CASP8 KO EL4 (EL4-C8KO) cell lysates after 24-hour treatment with tolinapant. F, Real-time microscopy (IncuCyte) measurement of membrane permeabilization by measuring Cytotox-NIR signal after treatment of EL4-PAR or EL4-C8KO cells with tolinapant.

Journal: Cancer Research Communications

Article Title: Epigenetic Priming by Hypomethylation Enhances the Immunogenic Potential of Tolinapant in T-cell Lymphoma

doi: 10.1158/2767-9764.CRC-23-0415

Figure Lengend Snippet: Effect of necrosome protein expression in TCL cell lines on tolinapant-induced cell death. A, Western blots of parental BW5147, RIPK3 − / − BW5147 and MLKL − / − BW5147 cell lysates (untreated). B, Cytotox-NIR signal captured by real-time microscopy (IncuCyte), detecting membrane permeabilization during lytic cell death after treatment of parental BW5147, RIPK3 − / − BW5147 and MLKL − / − BW5147 cells with tolinapant in the absence or presence of zVAD. C, Western blots of Karpas-299 cells transduced with control gRNA (KARPAS-299-CTR gRNA) or with RIPK3 gRNA (KARPAS-299-RIPK3 gRNA) constructs treated with tolinapant ± zVAD for 0, 2, or 6 hours. D, Real-time microscopy (IncuCyte) measurement of membrane permeabilization by measuring Cytotox-NIR signal after treatment of KARPAS-299-CTR gRNA or KARPAS-299-RIPK3 gRNA cells with tolinapant. E, Western blots of EL4-PAR and CASP8 KO EL4 (EL4-C8KO) cell lysates after 24-hour treatment with tolinapant. F, Real-time microscopy (IncuCyte) measurement of membrane permeabilization by measuring Cytotox-NIR signal after treatment of EL4-PAR or EL4-C8KO cells with tolinapant.

Article Snippet: EL4 (catalog no. 85023105, RRID:CVCL_0255) and Karpass-299 (catalog no. 06072604, RRID:CVCL_1324) cells were obtained from the European Collection of Authenticated Cell Cultures (ECACC, Salisbury, UK).

Techniques: Expressing, Western Blot, Microscopy, Membrane, Transduction, Control, Construct

Dosing with a combination of tolinapant plus decitabine drives increased efficacy in necroptosis-model of TCL (EL4-C8KO model). Volumes of EL4-PAR ( A ) and C8KO ( B ) EL4 tumors in wild-type mice treated with decitabine (0.3 mg/kg i.p., every day × 3 doses) and tolinapant dosing (25 mg/kg orally, every day × up to 46 doses) as single agents or in combination. C, Kaplan–Meier plot showing survival (tumors reaching 1,000 mm 3 as endpoint) of mice bearing EL4-C8KO (C8KO) tumors.

Journal: Cancer Research Communications

Article Title: Epigenetic Priming by Hypomethylation Enhances the Immunogenic Potential of Tolinapant in T-cell Lymphoma

doi: 10.1158/2767-9764.CRC-23-0415

Figure Lengend Snippet: Dosing with a combination of tolinapant plus decitabine drives increased efficacy in necroptosis-model of TCL (EL4-C8KO model). Volumes of EL4-PAR ( A ) and C8KO ( B ) EL4 tumors in wild-type mice treated with decitabine (0.3 mg/kg i.p., every day × 3 doses) and tolinapant dosing (25 mg/kg orally, every day × up to 46 doses) as single agents or in combination. C, Kaplan–Meier plot showing survival (tumors reaching 1,000 mm 3 as endpoint) of mice bearing EL4-C8KO (C8KO) tumors.

Article Snippet: EL4 (catalog no. 85023105, RRID:CVCL_0255) and Karpass-299 (catalog no. 06072604, RRID:CVCL_1324) cells were obtained from the European Collection of Authenticated Cell Cultures (ECACC, Salisbury, UK).

Techniques:

Eomes promoted the expression of IFN-γ mRNA in EL4 cells. ( A , B ) Whole cell lysates were prepared from Control #1, Control #2, Eomes #1, and Eomes #2 EL4 transfectants and used for Western blotting using anti-FLAG, anti-RelA, and anti-NFATc2 antibodies. Blots were representative of five independent experiments ( A ). The amount of FLAG-Eomes, RelA, and NFATc2 was normalized to that of γ1-actin. The amount of the FLAG-Eomes protein in the Eomes #2 EL4 transfectant was set to 1-fold. The amounts of the RelA protein and NFATc2 protein in the Control #1 EL4 transfectant were set to 1-fold. The FLAG-Eomes protein (fold), RelA protein (fold), and NFATc2 protein (fold) are shown as the mean ± S.E. of five independent experiments. ( C , D ) Control #1, Control #2, Eomes #1, and Eomes #2 EL4 transfectants were treated with (+) or without (−) PMA (10 nM) and IM (1 µM) for 6 h. IFN-γ mRNA ( C ) and IL-2 mRNA ( D ) were measured by quantitative PCR. mRNA levels without PMA and IM in each EL4 transfectant were set to 1-fold. Data are shown as the mean ± S.E. of three independent experiments. * p < 0.05, ** p < 0.01, and *** p < 0.001.

Journal: International Journal of Molecular Sciences

Article Title: Small Molecule Inhibitors Targeting Nuclear Factor κB Activation Markedly Reduce Expression of Interleukin-2, but Not Interferon-γ, Induced by Phorbol Esters and Calcium Ionophores

doi: 10.3390/ijms222313098

Figure Lengend Snippet: Eomes promoted the expression of IFN-γ mRNA in EL4 cells. ( A , B ) Whole cell lysates were prepared from Control #1, Control #2, Eomes #1, and Eomes #2 EL4 transfectants and used for Western blotting using anti-FLAG, anti-RelA, and anti-NFATc2 antibodies. Blots were representative of five independent experiments ( A ). The amount of FLAG-Eomes, RelA, and NFATc2 was normalized to that of γ1-actin. The amount of the FLAG-Eomes protein in the Eomes #2 EL4 transfectant was set to 1-fold. The amounts of the RelA protein and NFATc2 protein in the Control #1 EL4 transfectant were set to 1-fold. The FLAG-Eomes protein (fold), RelA protein (fold), and NFATc2 protein (fold) are shown as the mean ± S.E. of five independent experiments. ( C , D ) Control #1, Control #2, Eomes #1, and Eomes #2 EL4 transfectants were treated with (+) or without (−) PMA (10 nM) and IM (1 µM) for 6 h. IFN-γ mRNA ( C ) and IL-2 mRNA ( D ) were measured by quantitative PCR. mRNA levels without PMA and IM in each EL4 transfectant were set to 1-fold. Data are shown as the mean ± S.E. of three independent experiments. * p < 0.05, ** p < 0.01, and *** p < 0.001.

Article Snippet: Mouse lymphoma EL4 cells (RCB1641) were obtained from the RIKEN BioResource Research Center (Tsukuba, Japan).

Techniques: Expressing, Control, Western Blot, Transfection, Real-time Polymerase Chain Reaction

Binding of FLAG-Eomes, RelA, and NFATc2 to the IFN-γ promoter, CNS−22, and CNS+30 in EL4 transfectants. ( A – C ) The Control #2 EL4 transfectant (Control) and Eomes #2 EL4 transfectant (Eomes) were treated with (+) or without (−) PMA (10 nM) and IM (1 µM) for 2 h. ChIP assays were performed for FLAG-Eomes ( A ), RelA ( B ), and NFATc2 ( C ). Quantitative PCR was used to measure the amounts of fifteen different DNA regions. The IFN-γ promoter (−0.1 kb), CNS−22, and CNS+30 are shown in this figure. Other regions for FLAG-Eomes, RelA, and NFATc2 are shown in , respectively. Immunoprecipitated (IP) DNA (% input) is shown as the mean ± S.E. of three independent experiments. * p < 0.05, ** p < 0.01, and *** p < 0.001.

Journal: International Journal of Molecular Sciences

Article Title: Small Molecule Inhibitors Targeting Nuclear Factor κB Activation Markedly Reduce Expression of Interleukin-2, but Not Interferon-γ, Induced by Phorbol Esters and Calcium Ionophores

doi: 10.3390/ijms222313098

Figure Lengend Snippet: Binding of FLAG-Eomes, RelA, and NFATc2 to the IFN-γ promoter, CNS−22, and CNS+30 in EL4 transfectants. ( A – C ) The Control #2 EL4 transfectant (Control) and Eomes #2 EL4 transfectant (Eomes) were treated with (+) or without (−) PMA (10 nM) and IM (1 µM) for 2 h. ChIP assays were performed for FLAG-Eomes ( A ), RelA ( B ), and NFATc2 ( C ). Quantitative PCR was used to measure the amounts of fifteen different DNA regions. The IFN-γ promoter (−0.1 kb), CNS−22, and CNS+30 are shown in this figure. Other regions for FLAG-Eomes, RelA, and NFATc2 are shown in , respectively. Immunoprecipitated (IP) DNA (% input) is shown as the mean ± S.E. of three independent experiments. * p < 0.05, ** p < 0.01, and *** p < 0.001.

Article Snippet: Mouse lymphoma EL4 cells (RCB1641) were obtained from the RIKEN BioResource Research Center (Tsukuba, Japan).

Techniques: Binding Assay, Control, Transfection, Real-time Polymerase Chain Reaction, Immunoprecipitation

Effects of TPCA-1 on IFN-γ and IL-2 mRNA expression in EL4 transfectants. ( A – C ) Control #1, Control #2, Eomes #1, and Eomes #2 EL4 transfectants were pretreated with TPCA-1 for 1 h and then treated with (+) or without (−) PMA (10 nM) and IM (1 µM) for 2 h in the presence or absence of TPCA-1 at the indicated final concentrations. Cell viability (%) is shown as the mean ± S.E. of three independent experiments ( A ). IFN-γ mRNA ( B ) and IL-2 mRNA ( C ) were measured by quantitative PCR. mRNA levels with PMA and IM in each EL4 transfectant were set to 100%. IFN-γ mRNA (%) and IL-2 mRNA (%) are shown as the mean ± S.E. of three independent experiments. * p < 0.05, ** p < 0.01, and *** p < 0.001.

Journal: International Journal of Molecular Sciences

Article Title: Small Molecule Inhibitors Targeting Nuclear Factor κB Activation Markedly Reduce Expression of Interleukin-2, but Not Interferon-γ, Induced by Phorbol Esters and Calcium Ionophores

doi: 10.3390/ijms222313098

Figure Lengend Snippet: Effects of TPCA-1 on IFN-γ and IL-2 mRNA expression in EL4 transfectants. ( A – C ) Control #1, Control #2, Eomes #1, and Eomes #2 EL4 transfectants were pretreated with TPCA-1 for 1 h and then treated with (+) or without (−) PMA (10 nM) and IM (1 µM) for 2 h in the presence or absence of TPCA-1 at the indicated final concentrations. Cell viability (%) is shown as the mean ± S.E. of three independent experiments ( A ). IFN-γ mRNA ( B ) and IL-2 mRNA ( C ) were measured by quantitative PCR. mRNA levels with PMA and IM in each EL4 transfectant were set to 100%. IFN-γ mRNA (%) and IL-2 mRNA (%) are shown as the mean ± S.E. of three independent experiments. * p < 0.05, ** p < 0.01, and *** p < 0.001.

Article Snippet: Mouse lymphoma EL4 cells (RCB1641) were obtained from the RIKEN BioResource Research Center (Tsukuba, Japan).

Techniques: Expressing, Control, Real-time Polymerase Chain Reaction, Transfection

Effects of IKK-16 on IFN-γ and IL-2 mRNA expression in EL4 transfectants. ( A – C ) Control #1, Control #2, Eomes #1, and Eomes #2 EL4 transfectants were pretreated with IKK-16 for 1 h and then treated with (+) or without (−) PMA (10 nM) and IM (1 µM) for 2 h in the presence or absence of IKK-16 at the indicated final concentrations. Cell viability (%) is shown as the mean ± S.E. of three independent experiments ( A ). IFN-γ mRNA ( B ) and IL-2 mRNA ( C ) were measured by quantitative PCR. mRNA levels with PMA and IM in each EL4 transfectant were set to 100%. IFN-γ mRNA (%) and IL-2 mRNA (%) are shown as the mean ± S.E. of three independent experiments. * p < 0.05, ** p < 0.01, and *** p < 0.001.

Journal: International Journal of Molecular Sciences

Article Title: Small Molecule Inhibitors Targeting Nuclear Factor κB Activation Markedly Reduce Expression of Interleukin-2, but Not Interferon-γ, Induced by Phorbol Esters and Calcium Ionophores

doi: 10.3390/ijms222313098

Figure Lengend Snippet: Effects of IKK-16 on IFN-γ and IL-2 mRNA expression in EL4 transfectants. ( A – C ) Control #1, Control #2, Eomes #1, and Eomes #2 EL4 transfectants were pretreated with IKK-16 for 1 h and then treated with (+) or without (−) PMA (10 nM) and IM (1 µM) for 2 h in the presence or absence of IKK-16 at the indicated final concentrations. Cell viability (%) is shown as the mean ± S.E. of three independent experiments ( A ). IFN-γ mRNA ( B ) and IL-2 mRNA ( C ) were measured by quantitative PCR. mRNA levels with PMA and IM in each EL4 transfectant were set to 100%. IFN-γ mRNA (%) and IL-2 mRNA (%) are shown as the mean ± S.E. of three independent experiments. * p < 0.05, ** p < 0.01, and *** p < 0.001.

Article Snippet: Mouse lymphoma EL4 cells (RCB1641) were obtained from the RIKEN BioResource Research Center (Tsukuba, Japan).

Techniques: Expressing, Control, Real-time Polymerase Chain Reaction, Transfection

Effects of TPCA-1 on the binding of RelA, FLAG-Eomes, and NFATc2 to the IFN-γ promoter, CNS−22, and CNS+30 in EL4 transfectants. ( A – C ) Eomes #2 EL4 transfectants were pretreated with (+) or without (−) TPCA-1 for 1 h and then treated with (+) or without (−) PMA (10 nM) and IM (1 µM) for 2 h in the presence or absence of TPCA-1 (20 µM). ChIP assays were performed for FLAG-Eomes ( A ), RelA ( B ), and NFATc2 ( C ) using control IgG (light color bars) or specific antibodies (dark color bars). Quantitative PCR was used to measure the amounts of DNA regions. Immunoprecipitated (IP) DNA (% input) is shown as the mean ± S.E. of four ( A ) and three ( B , C ) independent experiments. * p < 0.05, ** p < 0.01, and *** p < 0.001.

Journal: International Journal of Molecular Sciences

Article Title: Small Molecule Inhibitors Targeting Nuclear Factor κB Activation Markedly Reduce Expression of Interleukin-2, but Not Interferon-γ, Induced by Phorbol Esters and Calcium Ionophores

doi: 10.3390/ijms222313098

Figure Lengend Snippet: Effects of TPCA-1 on the binding of RelA, FLAG-Eomes, and NFATc2 to the IFN-γ promoter, CNS−22, and CNS+30 in EL4 transfectants. ( A – C ) Eomes #2 EL4 transfectants were pretreated with (+) or without (−) TPCA-1 for 1 h and then treated with (+) or without (−) PMA (10 nM) and IM (1 µM) for 2 h in the presence or absence of TPCA-1 (20 µM). ChIP assays were performed for FLAG-Eomes ( A ), RelA ( B ), and NFATc2 ( C ) using control IgG (light color bars) or specific antibodies (dark color bars). Quantitative PCR was used to measure the amounts of DNA regions. Immunoprecipitated (IP) DNA (% input) is shown as the mean ± S.E. of four ( A ) and three ( B , C ) independent experiments. * p < 0.05, ** p < 0.01, and *** p < 0.001.

Article Snippet: Mouse lymphoma EL4 cells (RCB1641) were obtained from the RIKEN BioResource Research Center (Tsukuba, Japan).

Techniques: Binding Assay, Control, Real-time Polymerase Chain Reaction, Immunoprecipitation